INFLUENCE OF ANGIOTENSIN CONVERTING ENZYME POLYMORPHISM GENE, IGF-1 AND OTHER FACTORS IN THE RESPONSE RATE OF HEMATOCRIT TO ENALAPRIL TREATMENT IN PATIENTS WITH POSTTRANSPLANT ERYTHROCYTOSIS | Publicación